IBDEI03A ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2925,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,2925,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,2925,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,2926,0)
 ;;=F11.20^^20^208^2
 ;;^UTILITY(U,$J,358.3,2926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2926,1,3,0)
 ;;=3^Opioid Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,2926,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,2926,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,2927,0)
 ;;=M54.5^^20^208^1
 ;;^UTILITY(U,$J,358.3,2927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2927,1,3,0)
 ;;=3^Low Back Pain
 ;;^UTILITY(U,$J,358.3,2927,1,4,0)
 ;;=4^M54.5
 ;;^UTILITY(U,$J,358.3,2927,2)
 ;;=^5012311
 ;;^UTILITY(U,$J,358.3,2928,0)
 ;;=M19.90^^20^208^3
 ;;^UTILITY(U,$J,358.3,2928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2928,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,2928,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,2928,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,2929,0)
 ;;=F43.10^^20^209^6
 ;;^UTILITY(U,$J,358.3,2929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2929,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,2929,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,2929,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,2930,0)
 ;;=F43.12^^20^209^5
 ;;^UTILITY(U,$J,358.3,2930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2930,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,2930,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,2930,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,2931,0)
 ;;=F32.9^^20^209^3
 ;;^UTILITY(U,$J,358.3,2931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2931,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,2931,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,2931,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,2932,0)
 ;;=F41.9^^20^209^2
 ;;^UTILITY(U,$J,358.3,2932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2932,1,3,0)
 ;;=3^Anxiety Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,2932,1,4,0)
 ;;=4^F41.9
 ;;^UTILITY(U,$J,358.3,2932,2)
 ;;=^5003567
 ;;^UTILITY(U,$J,358.3,2933,0)
 ;;=F10.20^^20^209^1
 ;;^UTILITY(U,$J,358.3,2933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2933,1,3,0)
 ;;=3^Alcohol Dependence,Uncomp
 ;;^UTILITY(U,$J,358.3,2933,1,4,0)
 ;;=4^F10.20
 ;;^UTILITY(U,$J,358.3,2933,2)
 ;;=^5003081
 ;;^UTILITY(U,$J,358.3,2934,0)
 ;;=F06.8^^20^209^4
 ;;^UTILITY(U,$J,358.3,2934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2934,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,2934,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,2934,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,2935,0)
 ;;=F06.0^^20^209^7
 ;;^UTILITY(U,$J,358.3,2935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2935,1,3,0)
 ;;=3^Psychotic Disorder w/ Hallucinations d/t Physiol Condition
 ;;^UTILITY(U,$J,358.3,2935,1,4,0)
 ;;=4^F06.0
 ;;^UTILITY(U,$J,358.3,2935,2)
 ;;=^5003053
 ;;^UTILITY(U,$J,358.3,2936,0)
 ;;=E05.90^^20^210^14
 ;;^UTILITY(U,$J,358.3,2936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2936,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec
 ;;^UTILITY(U,$J,358.3,2936,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,2936,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,2937,0)
 ;;=E03.9^^20^210^9
 ;;^UTILITY(U,$J,358.3,2937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2937,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,2937,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,2937,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,2938,0)
 ;;=E11.9^^20^210^6
 ;;^UTILITY(U,$J,358.3,2938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2938,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,2938,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,2938,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,2939,0)
 ;;=E10.9^^20^210^1
 ;;^UTILITY(U,$J,358.3,2939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2939,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,2939,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,2939,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,2940,0)
 ;;=E11.65^^20^210^4
 ;;^UTILITY(U,$J,358.3,2940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2940,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,2940,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,2940,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,2941,0)
 ;;=E11.29^^20^210^2
 ;;^UTILITY(U,$J,358.3,2941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2941,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,2941,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,2941,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,2942,0)
 ;;=E11.40^^20^210^3
 ;;^UTILITY(U,$J,358.3,2942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2942,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,2942,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,2942,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,2943,0)
 ;;=E11.8^^20^210^5
 ;;^UTILITY(U,$J,358.3,2943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2943,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,2943,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,2943,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,2944,0)
 ;;=E78.0^^20^210^13
 ;;^UTILITY(U,$J,358.3,2944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2944,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,2944,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,2944,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,2945,0)
 ;;=E78.2^^20^210^12
 ;;^UTILITY(U,$J,358.3,2945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2945,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,2945,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,2945,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,2946,0)
 ;;=E78.5^^20^210^8
 ;;^UTILITY(U,$J,358.3,2946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2946,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,2946,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,2946,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,2947,0)
 ;;=M10.9^^20^210^7
 ;;^UTILITY(U,$J,358.3,2947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2947,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,2947,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,2947,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,2948,0)
 ;;=Z79.4^^20^210^11
 ;;^UTILITY(U,$J,358.3,2948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2948,1,3,0)
 ;;=3^Long Term (Current) Use of Insulin
 ;;^UTILITY(U,$J,358.3,2948,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,2948,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,2949,0)
 ;;=Z79.83^^20^210^10
 ;;^UTILITY(U,$J,358.3,2949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2949,1,3,0)
 ;;=3^Long Term (Current) Use of Bisphosphonates
 ;;^UTILITY(U,$J,358.3,2949,1,4,0)
 ;;=4^Z79.83
 ;;^UTILITY(U,$J,358.3,2949,2)
 ;;=^5063341
 ;;^UTILITY(U,$J,358.3,2950,0)
 ;;=I25.10^^20^211^1
 ;;^UTILITY(U,$J,358.3,2950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2950,1,3,0)
 ;;=3^Athscl Hrt Disease w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,2950,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,2950,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,2951,0)
 ;;=I25.9^^20^211^4
 ;;^UTILITY(U,$J,358.3,2951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2951,1,3,0)
 ;;=3^Ischemic Hrt Disease,Chronic Unspec
 ;;^UTILITY(U,$J,358.3,2951,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,2951,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,2952,0)
 ;;=I50.9^^20^211^3
 ;;^UTILITY(U,$J,358.3,2952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2952,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,2952,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,2952,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,2953,0)
 ;;=R03.0^^20^211^2
 ;;^UTILITY(U,$J,358.3,2953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2953,1,3,0)
 ;;=3^Elevated B/P w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,2953,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,2953,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,2954,0)
 ;;=J45.909^^20^212^2
 ;;^UTILITY(U,$J,358.3,2954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2954,1,3,0)
 ;;=3^Asthma,Uncomplicated
